What are the post‑procedure care instructions for a patient after an O‑shot (autologous platelet‑rich plasma injection into the vaginal area)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Post-Procedure Care Instructions for O-Shot (Platelet-Rich Plasma Vaginal Injection)

Based on current evidence, post-procedure care after O-shot should focus on avoiding NSAIDs for pain management, limiting sexual activity for 3-7 days, and monitoring for infection, though standardized protocols remain poorly defined in the literature.

Immediate Post-Procedure Period (First 24-48 Hours)

Pain Management

  • Avoid NSAIDs (ibuprofen, naproxen) immediately after injection as these may theoretically interfere with platelet function and growth factor release 1, 2
  • Use acetaminophen (Tylenol) for discomfort if needed
  • Apply ice packs externally to the vulvar area for 10-15 minutes at a time to reduce swelling
  • Mild discomfort, bruising, or swelling at injection sites is expected and typically resolves within 2-3 days

Activity Restrictions

  • Abstain from sexual intercourse for 3-7 days to allow initial tissue integration 3, 4
  • Avoid strenuous exercise or activities that increase pelvic pressure for 48 hours
  • No tampons, douching, or insertion of anything into the vagina for at least 3 days
  • Normal daily activities and walking are acceptable

Hygiene and Wound Care

  • Keep the area clean and dry
  • Gentle external washing with mild soap and water is permitted
  • Pat dry rather than rubbing
  • Wear loose, breathable cotton underwear
  • No swimming pools, hot tubs, or baths for 48-72 hours (showers are acceptable)

Days 3-14: Early Recovery Phase

Resuming Activities

  • Sexual activity may typically resume after 3-7 days if no bleeding or significant discomfort persists 3, 4
  • Gradually return to normal exercise routine after first week
  • Continue avoiding NSAIDs for the first 7-10 days if possible 2

Expected Changes

  • Some patients report increased sensitivity or mild tingling as tissue regeneration begins
  • Bruising should resolve within 7-10 days
  • Initial improvements in symptoms may begin as early as 2-4 weeks, though optimal results typically appear at 8-12 weeks 4

Follow-Up and Monitoring

Warning Signs Requiring Immediate Contact

  • Fever >100.4°F (38°C)
  • Increasing pain, redness, or warmth at injection sites
  • Purulent discharge or foul odor
  • Heavy vaginal bleeding
  • Signs of allergic reaction (though rare with autologous products) 1

Scheduled Follow-Up

  • First follow-up at 4-6 weeks to assess initial response 4
  • Many protocols involve 3-4 treatment sessions spaced 4-6 weeks apart for optimal results 4
  • Document baseline and post-treatment sexual function using validated scales (FSFI, FGSIS) 4

Important Caveats and Considerations

Safety Profile

Autologous PRP preparations are generally clinically safe with minimal adverse events reported across multiple studies 1, 3. The most common side effects are mild and transient: injection site discomfort, bruising, and temporary swelling 3, 5.

Lack of Standardization

A critical limitation is that PRP preparations are poorly standardized with wide variation in content, purity, and biological properties 1. This means outcomes may vary depending on:

  • Preparation method used by your provider
  • Platelet concentration achieved
  • Activation protocols employed
  • Injection technique and anatomical sites targeted

Evidence Quality

Current evidence for O-shot efficacy comes primarily from small case series and uncontrolled trials 3, 4. While results appear promising for sexual dysfunction and vaginal atrophy, definitive conclusions about efficacy require larger randomized controlled trials 1, 3.

Realistic Expectations

  • Not all patients respond equally to treatment
  • Multiple sessions are typically needed for optimal results 4
  • Effects are not permanent; maintenance treatments may be required
  • Individual results vary based on underlying condition severity and patient factors

Special Populations

Patients on Anticoagulation

  • Discuss with your provider before the procedure
  • May have increased bruising risk but procedure is generally safe

Active Infections

  • Any vaginal, urinary, or pelvic infection should be treated before PRP injection
  • Postpone procedure if active infection present

Immunocompromised Patients

  • While autologous products are generally safe, discuss individual risk-benefit ratio with provider 1

The key to successful outcomes is maintaining regular follow-up, adhering to activity restrictions during the critical first week, and having realistic expectations about the timeline for improvement 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.